Hannah Fry
Comptroller/Controller/Auditor at PROTARA THERAPEUTICS, INC.
Net worth: 91 000 $ as of 2024-04-29
Network origin in Hannah Fry first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 20 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Hannah Fry via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| CAMBREX CORPORATION | Pharmaceuticals: Generic | Director of Finance/CFO Director of Finance/CFO | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer Director of Finance/CFO Public Communications Contact | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PROGENICS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| DICERNA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ZS PHARMA INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
InClinica, Inc.
 InClinica, Inc. BiotechnologyHealth Technology InClinica, Inc. provides clinical trial services to western biotechnology, pharmaceutical and medical device companies. It also offers clinical trial management, pharmacovigilance and monitoring services. The company was founded in 2016 and is headquartered in Wayne, PA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| AFFYMAX, INC. | Biotechnology | Corporate Officer/Principal | |
SV Health Investors LLC
 SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Investment Managers | Corporate Officer/Principal | |
| Pace University | College/University | Undergraduate Degree | |
| The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of North Carolina at Chapel Hill | College/University | Undergraduate Degree | |
Coopers & Lybrand (London)
 Coopers & Lybrand (London) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., Coopers & Lybrand (London) is a British company that provides accounting services. The company is based in Edinburgh, UK. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| French-American Foundation | Director/Board Member | ||
| Exp@nets, Inc. | Director of Finance/CFO Director of Finance/CFO | ||
G&W Laboratories, Inc.
 G&W Laboratories, Inc. Pharmaceuticals: MajorHealth Technology G&W Laboratories, Inc. engages in the manufacturing and marketing pharmaceutical products. It offers generics and Rx products. The company was founded by Carl Greenblatt in 1919 and is headquartered in South Plainfield, NJ. | Pharmaceuticals: Major | Public Communications Contact | |
SWOG
 SWOG Hospital/Nursing ManagementHealth Services SWOG operates cancer clinics. The non-profit company is based in San Antonio, TX. | Hospital/Nursing Management | Corporate Officer/Principal | |
| ELECTROCORE, INC. | Medical Specialties | Director of Finance/CFO | |
| ENTERA BIO LTD. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Fluorinov Pharmaceuticals, Inc.
 Fluorinov Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fluorinov Pharmaceuticals, Inc. manufactures pharmaceutical products. The American company was founded by Abdelmalik Slassi. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SPERO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
| Eagleton Institute of Politics | College/University | Graduate Degree | |
| Escola Paulista De Medicina | College/University | Doctorate Degree | |
| DECIBEL THERAPEUTICS, INC. | Biotechnology | Chief Operating Officer | |
Vyera Pharmaceuticals LLC
 Vyera Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vyera Pharmaceuticals LLC operates as a biopharmaceutical company that focuses on patients with unmet medical needs. Its products include Vecamyl and Daraprim. The firm engages in developing and commercializing treatments for serious diseases and conditions of therapeutic areas. The company was founded by Martin Shkreli in October 10, 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
WindMIL Therapeutics, Inc.
 WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology WindMIL Therapeutics, Inc. operates as a biotechnology company. It develops immunotherapies for the treatment of cancer patients. The company was founded by Ivan Borrello and Kimberly Noonan and is headquartered in Baltimore, MD. | Medical Specialties | Director of Finance/CFO | |
Velocity Fund Partners
 Velocity Fund Partners Investment ManagersFinance Velocity Fund Partners (Velocity Fund Partners) is a private equity firm founded in 2016. The firm is headquartered in Pittsburgh, Pennsylvania. | Investment Managers | Chief Tech/Sci/R&D Officer | |
ArTara Subsidiary, Inc.
 ArTara Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ArTara Subsidiary, Inc. engages in the research and development of specialty diseases therapeutics. Its programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology or gastrointestinal and metabolic disorders. The company was founded by Jesse Shefferman in 2017 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Founder Corporate Officer/Principal | |
| BEYONDSPRING INC. | Pharmaceuticals: Major | Director/Board Member | |
| RAFAEL HOLDINGS, INC. | Real Estate Development | President | |
| ALKERMES PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Ribometrix, Inc.
 Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | Pharmaceuticals: Major | Chief Executive Officer | |
ValenzaBio, Inc.
 ValenzaBio, Inc. BiotechnologyHealth Technology ValenzaBio, Inc. develops safe and effective treatment options for patients with autoimmune and inflammatory diseases. The company is headquartered in Bethesda, MD. | Biotechnology | Director/Board Member |
Statistics
International
| United States | 45 |
| United Kingdom | 2 |
| Israel | 2 |
| Brazil | 2 |
| Ireland | 2 |
Sectoral
| Health Technology | 34 |
| Consumer Services | 8 |
| Finance | 5 |
| Commercial Services | 2 |
| Health Services | 2 |
Operational
| Director/Board Member | 63 |
| Corporate Officer/Principal | 46 |
| Independent Dir/Board Member | 31 |
| Director of Finance/CFO | 20 |
| Chief Tech/Sci/R&D Officer | 19 |
Most connected contacts
| Insiders | |
|---|---|
| Scott Braunstein | 25 |
| Luke Beshar | 19 |
| Richard Levy | 16 |
| Gregory Sargen | 15 |
| Michael Solomon | 14 |
| Patrick Fabbio | 13 |
| Cynthia Smith | 13 |
| Julio Casoy | 11 |
| Blaine Davis | 10 |
| Barry Flannelly | 10 |
| Jacqueline Zummo | 9 |
| Roger Garceau | 8 |
| Jane Huang | 8 |
| Justine O'Malley | 7 |
| Jathin Bandari | 7 |
- Stock Market
- Insiders
- Hannah Fry
- Company connections
